2021
DOI: 10.1007/s13312-021-2199-1
|View full text |Cite
|
Sign up to set email alerts
|

Steroids for the Management of Neonates With Meconium Aspiration Syndrome: A Systematic Review and Meta-analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 18 publications
0
4
0
Order By: Relevance
“…As lung cells may produce NO from L-arginine due to NOS activity, L-arginine in this study was used as a positive control. Although corticosteroids are among the most effective anti-inflammatory agents used to treat many inflammatory diseases [ 110 ], the use of steroids is not recommended by the Cochrane database for the treatment of MAS [ 111 ], and a meta-analysis showed that steroid use did not decrease mortality or associated morbidities [ 112 ]. However, our experience and those reported by others have indicated that the outcomes of infants with MAS can be significantly improved by the administration of both systemic and inhaled steroids [ 113 , 114 , 115 ].…”
Section: Discussionmentioning
confidence: 99%
“…As lung cells may produce NO from L-arginine due to NOS activity, L-arginine in this study was used as a positive control. Although corticosteroids are among the most effective anti-inflammatory agents used to treat many inflammatory diseases [ 110 ], the use of steroids is not recommended by the Cochrane database for the treatment of MAS [ 111 ], and a meta-analysis showed that steroid use did not decrease mortality or associated morbidities [ 112 ]. However, our experience and those reported by others have indicated that the outcomes of infants with MAS can be significantly improved by the administration of both systemic and inhaled steroids [ 113 , 114 , 115 ].…”
Section: Discussionmentioning
confidence: 99%
“…As lung cells may produce NO from L-arginine due to NOS activity, L-arginine in this study was used as a positive control. Although corticosteroids are among the most effective anti-inflammatory agents used to treat many inflammatory diseases [110], the use of steroids is not recommended by the Cochrane database for the treatment of MAS [111], and a meta-analysis showed that steroid use did not decrease mortality or associated morbidities [112]. However, our experience and those reported by others have indicated that the outcomes of infants with MAS can be significantly improved by the administration of both systemic and inhaled steroids [113][114][115].…”
Section: Discussionmentioning
confidence: 77%
“…Steroids reduce pulmonary inflammation on histology and improve oxygenation in animal studies. 23,24 Two recently published systematic reviews 25,26 have evaluated the role of steroids in MAS. There was no mortality benefit, but reduced hospital stay with…”
Section: Discussionmentioning
confidence: 99%